221 related articles for article (PubMed ID: 30130801)
1. Securing Hemostasis in Pediatric Low-Grade Posterior Cerebral Fossa Tumors: The Value of Thrombin-Gelatin Hemostatic Matrix.
Baro V; Denaro L; d'Avella D
Pediatr Neurosurg; 2018; 53(5):330-336. PubMed ID: 30130801
[TBL] [Abstract][Full Text] [Related]
2. Incidence of thromboembolic events after use of gelatin-thrombin-based hemostatic matrix during intracranial tumor surgery.
Gazzeri R; Galarza M; Conti C; De Bonis C
Neurosurg Rev; 2018 Jan; 41(1):303-310. PubMed ID: 28439721
[TBL] [Abstract][Full Text] [Related]
3. Use of gelatin-thrombin matrix hemostatic sealant in cranial neurosurgery.
Fiss I; Danne M; Stendel R
Neurol Med Chir (Tokyo); 2007 Oct; 47(10):462-7. PubMed ID: 17965563
[TBL] [Abstract][Full Text] [Related]
4. Prospective, randomized, controlled clinical trial of a novel matrix hemostatic sealant in children undergoing adenoidectomy.
Mathiasen RA; Cruz RM
Otolaryngol Head Neck Surg; 2004 Nov; 131(5):601-5. PubMed ID: 15523433
[TBL] [Abstract][Full Text] [Related]
5. Use of gelatin matrix thrombin tissue sealant as an effective hemostatic agent during laparoscopic partial nephrectomy.
Bak JB; Singh A; Shekarriz B
J Urol; 2004 Feb; 171(2 Pt 1):780-2. PubMed ID: 14713810
[TBL] [Abstract][Full Text] [Related]
6. A gelatin-thrombin matrix for hemostasis after endoscopic sinus surgery.
Woodworth BA; Chandra RK; LeBenger JD; Ilie B; Schlosser RJ
Am J Otolaryngol; 2009; 30(1):49-53. PubMed ID: 19027513
[TBL] [Abstract][Full Text] [Related]
7. Comparison the efficacy of hemorrhage control of Surgiflo Haemostatic Matrix and absorbable gelatin sponge in posterior lumbar surgery: A randomized controlled study.
Ma L; Dai L; Yang Y; Liu H
Medicine (Baltimore); 2018 Dec; 97(49):e13511. PubMed ID: 30544449
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of clinical effects of absorbable hemostatic fluid gelatin and absorbable gelatin sponge on the hemostasis during operation of unilateral open-door cervical expansive laminoplasty].
Li GZ; Hong Y; Liu H; Ma LT; Yang Y; Ding C; Wang BY; Chen H
Zhongguo Gu Shang; 2017 Sep; 30(9):849-852. PubMed ID: 29455488
[TBL] [Abstract][Full Text] [Related]
9. An In Vivo Comparison of Hemostatic Gelatin Matrix Products in a Porcine Spleen Biopsy-punch Model.
Hutchinson RW; Werrlein S; Johns DB; Zhang G; Clymer JW; Kocharian R
Surg Technol Int; 2015 Nov; 27():53-7. PubMed ID: 26680379
[TBL] [Abstract][Full Text] [Related]
10. Haemostasis in neurosurgery: what is the evidence for gelatin-thrombin matrix sealant?
Yao HH; Hong MK; Drummond KJ
J Clin Neurosci; 2013 Mar; 20(3):349-56. PubMed ID: 23384508
[TBL] [Abstract][Full Text] [Related]
11. Prospective clinical trial of gelatin-thrombin matrix as first line treatment of posterior epistaxis.
Kilty SJ; Al-Hajry M; Al-Mutairi D; Bonaparte JP; Duval M; Hwang E; Tse D
Laryngoscope; 2014 Jan; 124(1):38-42. PubMed ID: 23754469
[TBL] [Abstract][Full Text] [Related]
12. Reducing blood loss at myomectomy with use of a gelatin-thrombin matrix hemostatic sealant.
Raga F; Sanz-Cortes M; Bonilla F; Casañ EM; Bonilla-Musoles F
Fertil Steril; 2009 Jul; 92(1):356-60. PubMed ID: 19423098
[TBL] [Abstract][Full Text] [Related]
13. Intra-operative MRI-guided approaches to the pediatric posterior fossa tumors.
Lam CH; Hall WA; Truwit CL; Liu H
Pediatr Neurosurg; 2001 Jun; 34(6):295-300. PubMed ID: 11455229
[TBL] [Abstract][Full Text] [Related]
14. Control of major pulmonary artery bleeding with a gelatin matrix-thrombin solution: a retrospective analysis.
Cardillo G; Carleo F; DI Martino M; Ciamberlano B; Ialongo P; Cusumano G; Denitza Tinti M; Ricci A; Cafarotti S
J Cardiovasc Surg (Torino); 2017 Dec; 58(6):904-908. PubMed ID: 26337014
[TBL] [Abstract][Full Text] [Related]
15. Association between gelatin-thrombin matrix use and abscesses in women undergoing pelvic surgery.
Anderson CK; Medlin E; Ferriss AF; Sheeder J; Davidson S; Gibbs R; Behbakht K; Guntupalli SR
Obstet Gynecol; 2014 Sep; 124(3):589-595. PubMed ID: 25162261
[TBL] [Abstract][Full Text] [Related]
16. Gelatin-thrombin hemostatic matrix in neurosurgical procedures: hemostatic effectiveness and economic value of clinical and surgical procedure-related benefits.
Esposito F; Cappabianca P; Angileri FF; Cavallo LM; Priola SM; Crimi S; Solari D; Germanò AF; Tomasello F
J Neurosurg Sci; 2020 Apr; 64(2):158-164. PubMed ID: 27456032
[TBL] [Abstract][Full Text] [Related]
17. Comparison of two gelatin and thrombin combination hemostats in a porcine liver abrasion model.
Lewis KM; Atlee HD; Mannone AJ; Dwyer J; Lin L; Goppelt A; Redl H
J Invest Surg; 2013 Jun; 26(3):141-8. PubMed ID: 23514063
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a gelatin matrix as a topical hemostatic agent for hepatic bleeding in the dog.
Polidoro DP; Kass PH
J Am Anim Hosp Assoc; 2013; 49(5):308-17. PubMed ID: 23861265
[TBL] [Abstract][Full Text] [Related]
19. Cost-consequence analysis of a hemostatic matrix alone or in combination for spine surgery patients.
Ramirez MG; Niu X; Epstein J; Yang D
J Med Econ; 2018 Oct; 21(10):1041-1046. PubMed ID: 30112922
[TBL] [Abstract][Full Text] [Related]
20. A Gelatin-Thrombin Matrix Topical Hemostatic Agent (Floseal) in Combination With Harmonic Scalpel Is Effective in Patients Undergoing Total Thyroidectomy: A Prospective, Multicenter, Single-Blind, Randomized Controlled Trial.
Docimo G; Tolone S; Conzo G; Limongelli P; Del Genio G; Parmeggiani D; De Palma M; Lupone G; Avenia N; Lucchini R; Monacelli M; Gulotta G; Scerrino G; Pasquali D; Bellastella G; Esposito K; De Bellis A; Pezzolla A; Ruggiero R; Docimo L
Surg Innov; 2016 Feb; 23(1):23-9. PubMed ID: 26243629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
